Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker BNTX
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Medine GmbH Officer, 10% Stockholder | BNTX BioNTech SE | 858,209 | $89.1M | — | Sep 3, 2026 | — | Form 144 ↗ |
| May 12, 2026 | Medine GmbH Officer, 10% Stockholder | BNTX BioNTech SE | 858,209 | $80.4M | — | May 13, 2026 | — | Form 144 ↗ |
| Mar 11, 2026 | Poetting Sierk Officer | BNTX BioNTech SE | 150,000 | $12.6M | — | Mar 11, 2026 | Form 4 ↗ 43 days later · 50,000 shares | Form 144 ↗ |
| Feb 12, 2026 | Medine GmbH Officer, 10% Stockholder | BNTX BioNTech SE | 858,209 | $93.9M | — | Feb 12, 2026 | — | Form 144 ↗ |
| Nov 28, 2025 | Tureci Ozlem Officer | BNTX BioNTech SE | 123,331 | $12.7M | — | Nov 28, 2025 | — | Form 144 ↗ |
| Nov 13, 2025 | Medine GmbH Officer, 10% Stockholder | BNTX BioNTech SE | 1.11M | $124.4M | — | Nov 13, 2025 | — | Form 144 ↗ |
| Nov 5, 2025 | Jeggle Helmut Wolfgang Director | BNTX BioNTech SE | 150,000 | $15.5M | — | Nov 5, 2025 | — | Form 144 ↗ |
| Sep 5, 2025 | Athos KG 10% Stockholder | BNTX BioNTech SE | 500,000 | $56.2M | — | Sep 5, 2025 | — | Form 144 ↗ |
| Aug 15, 2025 | Medine GmbH Officer, 10% Stockholder | BNTX BioNTech SE | 1.77M | $200.0M | — | Aug 15, 2025 | — | Form 144 ↗ |
| Aug 15, 2025 | Tureci Ozlem Officer | BNTX BioNTech SE | 185,001 | $20.8M | — | Aug 15, 2025 | — | Form 144 ↗ |
| Jun 4, 2025 amended | Athos KG 10% Stockholder | BNTX BioNTech SE | 325,000 | $36.8M | — | May 28, 2025 | — | Form 144/A ↗ |
| Jun 4, 2025 | Jeggle Helmut Wolfgang Director | BNTX BioNTech SE | 150,000 | $17.0M | — | Jun 4, 2025 | — | Form 144 ↗ |
| Jun 2, 2025 | Athos KG 10% Stockholder | BNTX BioNTech SE | 175,000 | $19.4M | — | Jun 2, 2025 | — | Form 144 ↗ |
| May 28, 2025 | Athos KG 10% Stockholder | BNTX BioNTech SE | 500,000 | $49.3M | — | May 28, 2025 | — | Form 144 ↗ |
| May 7, 2025 | Jeggle Helmut Wolfgang Director | BNTX BioNTech SE | 150,000 | $14.2M | — | May 7, 2025 | — | Form 144 ↗ |
| Feb 27, 2025 | Ryan Richardson Officer | BNTX BioNTech SE | 26,500 | $3.0M | — | Feb 27, 2025 | — | Form 144 ↗ |
| Feb 20, 2025 | Medine GmbH Officer, 10% Stockholder | BNTX BioNTech SE | 1.00M | $119.6M | — | Feb 20, 2025 | — | Form 144 ↗ |
| Feb 20, 2025 | Poetting Sierk Officer | BNTX BioNTech SE | 120,000 | $14.3M | — | Feb 20, 2025 | — | Form 144 ↗ |
| Dec 13, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 4,983 | $601.4K | — | Dec 13, 2024 | — | Form 144 ↗ |
| Dec 11, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 22,450 | $2.6M | — | Dec 11, 2024 | — | Form 144 ↗ |
| Dec 9, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 53,716 | $6.5M | — | Dec 9, 2024 | — | Form 144 ↗ |
| Dec 6, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 13,104 | $1.6M | — | Dec 6, 2024 | — | Form 144 ↗ |
| Nov 27, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 44,374 | $5.3M | — | Nov 27, 2024 | — | Form 144 ↗ |
| Nov 26, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 10,000 | $1.2M | — | Nov 26, 2024 | — | Form 144 ↗ |
| Nov 25, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 75,000 | $8.5M | — | Nov 25, 2024 | — | Form 144 ↗ |
| Nov 15, 2024 | Jeggle Helmut Wolfgang Director | BNTX BioNTech SE | 150,000 | $15.5M | — | Nov 15, 2024 | — | Form 144 ↗ |
| Nov 12, 2024 | Tureci Ozlem Officer | BNTX BioNTech SE | 556,000 | $60.5M | — | Nov 12, 2024 | — | Form 144 ↗ |
| Oct 16, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 8,036 | $946.2K | — | Oct 16, 2024 | — | Form 144 ↗ |
| Oct 15, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 25,424 | $3.1M | — | Oct 14, 2024 | — | Form 144 ↗ |
| Oct 11, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 40,000 | $4.8M | — | Oct 11, 2024 | — | Form 144 ↗ |
| Oct 10, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 20,000 | $2.3M | — | Oct 10, 2024 | — | Form 144 ↗ |
| Oct 9, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 6,000 | $714.4K | — | Oct 9, 2024 | — | Form 144 ↗ |
| Oct 8, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 15,000 | $1.8M | — | Oct 8, 2024 | — | Form 144 ↗ |
| Oct 7, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 20,295 | $2.5M | — | Oct 7, 2024 | — | Form 144 ↗ |
| Oct 4, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 14,756 | $1.8M | — | Oct 4, 2024 | — | Form 144 ↗ |
| Oct 3, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 50,000 | $6.0M | — | Oct 3, 2024 | — | Form 144 ↗ |
| Oct 2, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 65,200 | $7.8M | — | Oct 2, 2024 | — | Form 144 ↗ |
| Oct 1, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 72,086 | $8.6M | — | Oct 1, 2024 | — | Form 144 ↗ |
| Sep 30, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 76,114 | $9.0M | — | Sep 30, 2024 | — | Form 144 ↗ |
| Sep 27, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 37,204 | $4.4M | — | Sep 27, 2024 | — | Form 144 ↗ |
| Sep 25, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 37,943 | $4.5M | — | Sep 25, 2024 | — | Form 144 ↗ |
| Sep 18, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 55,605 | $6.9M | — | Sep 18, 2024 | — | Form 144 ↗ |
| Sep 17, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 30,162 | $3.8M | — | Sep 17, 2024 | — | Form 144 ↗ |
| Sep 16, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 90,000 | $11.3M | — | Sep 16, 2024 | — | Form 144 ↗ |
| Sep 16, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 500,000 | $61.7M | — | Sep 16, 2024 | — | Form 144 ↗ |
| Sep 13, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 170,000 | $19.6M | — | Sep 13, 2024 | — | Form 144 ↗ |
| Feb 28, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 100,000 | $9.3M | — | Feb 28, 2024 | — | Form 144 ↗ |
| Jan 4, 2024 | Athos KG 10% Stockholder | BNTX BioNTech SE | 1.00M | $112.3M | — | Jan 4, 2024 | — | Form 144 ↗ |
| Oct 10, 2023 amended | Athos KG 10% Stockholder | BNTX BioNTech SE | 2.18M | $238.3M | — | Oct 10, 2023 | — | Form 144/A ↗ |
| Sep 29, 2023 | Jeggle Helmut Wolfgang Director | BNTX BioNTech SE | 200,000 | $20.9M | — | Sep 29, 2023 | — | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:46 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances